Carmustine and Ribavirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carmustine (carmustine) and Ribavirin (ribavirin). Common drug interactions include hepatitis e among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Carmustine and Ribavirin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.



On Jul, 18, 2026

20 people who take Carmustine and Ribavirin together, and have interactions are studied.

Carmustine and Ribavirin drug interactions.

What are the common drug interactions of Carmustine and Ribavirin, by gender? *:

female:

  1. Hepatitis e
  2. Adenovirus infection
  3. Anaemia (lack of blood)
  4. Bk virus infection
  5. Drug ineffective
  6. Gastroenteritis adenovirus (inflammation of stomach and intestine by adeno virus infection)
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Nausea (feeling of having an urge to vomit)
  9. Respiratory syncytial virus infection (viral disease of respiratory system)
  10. Thrombocytopenia (decrease of platelets in blood)

male:

  1. Fatigue (feeling of tiredness)
  2. Hepatic failure (liver failure)
  3. Pneumonia mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection)
  4. Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
  5. Abdominal pain upper
  6. Anaemia (lack of blood)
  7. Decreased appetite
  8. Epistaxis (bleed from the nose)
  9. Insomnia (sleeplessness)
  10. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

What are the common drug interactions of Carmustine and Ribavirin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hepatitis e
  2. Adenovirus infection
  3. Anaemia (lack of blood)
  4. Bk virus infection
  5. Drug ineffective
  6. Gastroenteritis adenovirus (inflammation of stomach and intestine by adeno virus infection)
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Nausea (feeling of having an urge to vomit)
  9. Respiratory syncytial virus infection (viral disease of respiratory system)
  10. Thrombocytopenia (decrease of platelets in blood)

50-59:

  1. Local swelling (swelling at the site of some application of substance or injury)
  2. Pruritus (severe itching of the skin)
  3. Rash
  4. Bacteraemia (presence of bacteria in the blood)
  5. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  6. Diarrhoea
  7. Drug ineffective
  8. Dysgeusia (disorder of the sense of taste)
  9. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  10. Hypoxia (low oxygen in tissues)

60+:

  1. Hepatic failure (liver failure)
  2. Abdominal pain upper
  3. Decreased appetite
  4. Fatigue (feeling of tiredness)
  5. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  6. Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

  1. Hepatitis E: 6 people, 30.00%
  2. Bone Marrow Conditioning Regimen: 6 people, 30.00%
  3. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 20.00%
  4. Thyroid Cancer: 3 people, 15.00%
  5. Pneumonia Respiratory Syncytial Viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children): 3 people, 15.00%
  6. Multiple Myeloma (cancer of the plasma cells): 3 people, 15.00%
  7. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 15.00%
  8. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 3 people, 15.00%
  9. Respiratory Syncytial Virus Infection (viral disease of respiratory system): 2 people, 10.00%
  10. Diarrhea: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and Ribavirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carmustine and Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carmustine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carmustine and ribavirin (the active ingredients of Carmustine and Ribavirin, respectively), and Carmustine and Ribavirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: